A new study published in Advanced Science has revealed how curcumin, a bioactive compound found in Curcuma aromatica (Yujin), can help mitigate neuroinflammation and brain damage caused by epileptic ...

A new study has found that a bioactive compound found in coffee beans improved learning and memory decline in aged mice. The findings open the door to developing a supplementary medicinal compound to ...

Insilico Medicine has received investigational new drug clearance from the US Food and Drug Administration for ISM8969, an oral, brain-penetrant inhibitor of the NOD-like receptor family pyrin ...

In recent years, there's been a growing awareness of neuroinflammation, an immune response in the brain. Research suggests that chronic inflammatory activation could be a central driver behind many ...

Alzheimer’s disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from the ...

Microglia are becoming an increasingly crucial component of in vitro neurodegenerative disease research. This webinar will explore the vital topic of understanding neuroinflammation, focusing on human ...

The Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 20-21, 2017 that brought together key stakeholders from government, academia, industry, and disease-focused ...

New findings discussed at the latest Alzheimer’s Association International Conference (AAIC) highlight the risk factors associated with Alzheimer’s disease. Amongst the risks are inflammation-related ...